Declining death rates reflect progress against cancer

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Jemal, Ahmedin ^a   Ward, Elizabeth ^a   Thun, Michael ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CIGARETTE SMOKING; COLORECTAL CANCER; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; GROUPS BY AGE; HEALTH CARE ACCESS; HEALTH CARE QUALITY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; RACE DIFFERENCE; RISK REDUCTION; SEX DIFFERENCE; UNITED STATES; AGE DISTRIBUTION; CANCER REGISTRY; ETHNIC GROUP; MIDDLE AGED; MORTALITY; NEOPLASM; ONCOLOGY; REGISTER; REGRESSION ANALYSIS; SEX RATIO; STATISTICS;

NICOTIANA TABACUM;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASMS; REGISTRIES; REGRESSION ANALYSIS; SEER PROGRAM; SEX DISTRIBUTION;

EID: 77949726422     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009584     Document Type: Article

References (76)

1. Cole P, Rodu B (1996) Declining cancer mortality in the United States. Cancer 78: 2045-2048.
2. Jemal A, Thun MJ, Ries LA, Howe HL, Weir HK, et al. (2008) Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst 100: 1672-1694.
3. Simone J (2010) Winning th war against cancer, onr battle at a time. Cancer. pp 263-262.
4. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, et al. (2009) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer.
5. Begley S (2008) We fought cancer...and cancer won. Newsweek 152: 42-44, 46, 57-48 passim.
6. Kolata G (2009) Advances elusive in the long drive to cure cancer. The New York Times Helath. New York: The New York Times Company.
7. Leaf C (2004) Why we're losing the war on cancer (and how to win it). Fortune 149: 76-82, 84-76, 88 passim.
8. Bailar JC, 3rd, Gornik HL (1997) Cancer undefeated. N Engl J Med 336: 1569-1574.
9. Harris G (2009) Where cancer progress is rare, one man says no. The New York Times Health September 15, 2009 http://wwwnytimescom/2009/09/16/health/ policy/16cancerhtml?hp September 16, 2009. New York.
10. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer. cancer.gov) SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2006) 〈Katrina/Rita Population Adjustment〉, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released May 2009. Underlying mortality data provided by NCHS (www.cdc.gov/nchs).
11. SEER Cause of Death Recode. http://seer.cancer.gov/codrecode/index.html. September 10, 2009.
12. Surveillance Research Program, National Cancer Institute SEER*Stat software (www.seer.cancer.gov/seerstat) version 6.5.2. September 14, 2009.
13. Anderson R, Rosenberg H (1998) Age standardization of death rates: implementation of the year 2000 standard. National Vital Statistics Reports 47: 16.
14. Thun M, Jemal A (2006) Cancer Epidemiology. In: Kufe D, Bast R Jr, Hait W, Hong W, Pollock R, et al. (2006) Cancer Medicine. London: BC Becker Inc. pp 339-353.
15. Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335-351.
16. Gardner JW, Sanborn JS (1990) Years of potential life lost (YPLL)-what does it measure? Epidemiology 1: 322-329.
17. Edwards BK, Brown ML, Wingo PA, Howe HL, Ward E, et al. (2005) Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97: 1407-1427.
18. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, et al. (2009) Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116: 544-573.
19. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, et al. (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101: 3-27.
20. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, et al. (2003) Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 95: 1276-1299.
21. Thun MJ, Jemal A (2006) How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control 15: 345-347.
22. National Center for Health Statistics. Health, United States, 2008. With Chartbook. Hyattsville, MD: 2009.
23. U.S. Department of Health and Human Services The Health Consequences of Smoking: A report of the Surgeon General. Atlanta, GA: U.S. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office of Smoking and Health, 2004).
24. Chu KC, Kramer BS, Smart CR (1991) Analysis of the role of cancer prevention and control measures in reducing cancer mortality. J Natl Cancer Inst 83: 1636-1643.
25. Brown LM, Devesa SS (2002) Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 11: 235-256.
26. Wingo PA, Cardinez CJ, Landis SH, Greenlee RT, Ries LA, et al. (2003) Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 97: 3133-3275.
27. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, et al. (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792.
28. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, et al. (1993) Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 329: 1977-1981.
29. Koss LG (1989) The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 261: 737-743.
30. Sherman ME, Wang SS, Carreon J, Devesa SS (2005) Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival. Cancer 103: 1258-1264.
31. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R (2001) Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 93: 1704-1713.
32. Breen N, K AC, Meissner HI, Taplin SH, Tangka FK, et al. (2007) Reported drop in mammography: is this cause for concern? Cancer 109: 2405-2409.
33. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC (2003) Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer 97: 1528-1540.
34. Meissner HI, Breen N, Klabunde CN, Vernon SW (2006) Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 15: 389-394.
35. Chu KC, Tarone RE, Freeman HP (2003) Trends in prostate cancer mortality among black men and white men in the United States. Cancer 97: 1507-1516.
36. Etzioni R, Tsodikov A, Mariotto A, Szabo A, Falcon S, et al. (2008) Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control 19: 175-181.
37. Feuer EJ, Mariotto A, Merrill R (2002) Modeling the impact of the decline in distant stage disease on prostate carcinoma mortality rates. Cancer 95: 870-880.
38. Schroder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, et al. (2009) Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 360: 1320-1328.
39. Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, et al. (2009) Mortality results from a randomized prostate-cancer screening trial. NEngl J Med 360: 1310-1319.
40. Baade PD, Youlden DR, Krnjacki LJ (2009) International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 53: 171-184.
41. Collin SM, Martin RM, Metcalfe C, Gunnell D, Albertsen PC, et al. (2008) Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study. Lancet Oncol 9: 445-452.
42. Oliver SE, May MT, Gunnell D (2001) International trends in prostate-cancer mortality in the "PSA ERA". Int J Cancer 92: 893-898.
43. Feuer EJ, Merrill RM, Hankey BF (1999) Cancer surveillance series: interpreting trends in prostate cancer-part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 91: 1025-1032.
44. Devita VT, Jr., Serpick AA, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73: 881-895.
45. Einhorn LH, Donohue JP (1977) Chemotherapy for disseminated testicular cancer. Urol Clin North Am 4: 407-426.
46. Einhorn LH, Donohue JP (1977) Improved chemotherapy in disseminated testicular cancer. J Urol 117: 65-69.
47. Balis F, Holcenberg J, Blaney S (2002) General principles of chemotherapy. In: Pizzo p, Poplack D, eds. Priciples and practice of pediatric oncology. Philadelphia: Williams & Wilkins. pp 237-308.
48. Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ (2002) Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst 94: 1204-1210.
49. El-Serag HB, Mason AC (2000) Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 160: 3227-3230.
50. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348: 1625-1638.
51. Howe HL, Wingo PA, Thun MJ, Ries LA, Rosenberg HM, et al. (2001) Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 93: 824-842.
52. Chow WH, Blot WJ, Vaughan TL, Risch HA, Gammon MD, et al. (1998) Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90: 150-155.
53. Silverman DT, Dunn JA, Hoover RN, Schiffman M, Lillemoe KD, et al. (1994) Cigarette smoking and pancreas cancer: a case-control study based on direct interviews. J Natl Cancer Inst 86: 1510-1516.
54. Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA, Jr. (2006) Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354: 2340-2348.
55. Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J (2003) Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290: 66-72.
56. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF, Jr. (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265: 1287-1289.
57. Jemal A, Devesa SS, Hartge P, Tucker MA (2001) Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 93: 678-683.
58. Thun MJ, Henley SJ, Calle EE (2002) Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21: 7307-7325.
59. (2005) Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wkly Rep 54: 625-628.
60. Smedley BD, Stith AY, Nelson AR, eds (2002) Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press.
61. Chu KC, Lamar CA, Freeman HP (2003) Racial disparities in breast carcinoma survival rates: seperating factors that affect diagnosis from factors that affect treatment. Cancer 97: 2853-2860.
62. Boffetta P, La Vecchia C, Levi F, Lucchini F (1993) Mortality patterns and trends for lung cancer and other tobacco-related cancers in the Americas, 1955-1989. Int J Epidemiol 22: 377-384.
63. Bray FI, Weiderpass E (2009) Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer 126: 1454-1466.
64. Giles GG, Hill DJ, Silver B (1991) The lung cancer epidemic in Australia, 1910 to 1989. Aust J Public Health 15: 245-247.
65. Shafey O, Dolwick S, Guindon G (2003) Tobacco Control Country Profiles.
66. Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 34: 405-412.
67. Levi F, Bosetti C, Lucchini F, Negri E, La Vecchia C (2005) Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 14: 497-502.
68. Tarone RE, Chu KC, Gaudette LA (1997) Birth cohort and calendar period trends in breast cancer mortality in the United States and Canada. J Natl Cancer Inst 89: 251-256.
69. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A (2009) Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 45: 2640-2648.
70. Robles SC, White F, Peruga A (1996) Trends in cervical cancer mortality in the Americas. Bull Pan Am Health Organ 30: 290-301.
71. Taylor RJ, Morrell SL, Mamoon HA, Wain GV (2001) Effects of screening on cervical cancer incidence and mortality in New South Wales implied by influences of period of diagnosis and birth cohort. J Epidemiol Community Health 55: 782-788.
72. Hoel DG, Ron E, Carter R, Mabuchi K (1993) Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst 85: 1063-1068.
73. Percy C, Stanek E, 3rd, Gloeckler L (1981) Accuracy of cancer death certificates and its effect on cancer mortality statistics. Am J Public Health 71: 242-250.
74. Jemal A, Ward E, Anderson RN, Thun MJ (2003) Influence of rules from the Tenth Revision of the International Classification of Diseases on U.S. cancer mortality trends. J Natl Cancer Inst 95: 1727-1728.
75. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM (2001) Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep 49: 1-32.
76. McCracken M, Olsen M, Chen MS, 3rd, Jemal A, Thun M, et al. (2007) Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 57: 190-205.